Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial

INTRODUCTION: The efficacy and safety of galcanezumab as a preventive treatment in Japanese patients with episodic migraine was demonstrated in a phase 2, randomized, placebo-controlled trial (conducted December 2016–January 2019). This post hoc analysis assessed the consistency of galcanezumab effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Mamoru, Nihira, Atsuko, Tanji, Yuka, Ozeki, Akichika, Imagawa, Hideyuki, Komori, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630272/
https://www.ncbi.nlm.nih.gov/pubmed/37698836
http://dx.doi.org/10.1007/s40120-023-00534-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630272/
https://www.ncbi.nlm.nih.gov/pubmed/37698836
http://dx.doi.org/10.1007/s40120-023-00534-0

Ejemplares similares